Vaxcyte
PCVX
PCVX
328 hedge funds and large institutions have $15.6B invested in Vaxcyte in 2024 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 131 increasing their positions, 87 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% more call options, than puts
Call options by funds: $90.6M | Put options by funds: $61.4M
24% more funds holding
Funds holding: 265 → 328 (+63)
0.59% less ownership
Funds ownership: 112.66% → 112.07% (-0.59%)
Holders
328
Holding in Top 10
23
Calls
$90.6M
Puts
$61.4M
Top Buyers
| 1 | +$185M | |
| 2 | +$148M | |
| 3 | +$117M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$91.8M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$89.7M |
Top Sellers
| 1 | -$46M | |
| 2 | -$36.9M | |
| 3 | -$34.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$33M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$32.1M |